Shandong Lukang Pharmaceutical (600789.SH) has received approval from the China Securities Regulatory Commission to issue stocks to specific entities.

Shandong Lukang Pharmaceutical (600789.SH) has announced that the company has recently received approval from the China Securities Regulatory Commission (referred to as the "CSRC") for the registration of issuing stocks to specific investors. The approval is granted in the document titled "Approval for Shandong Lukang Pharmaceutical Co., Ltd. to Issue Stocks to Specific Investors" (CSRC Permit [2025] 2158). The company's registration application to issue stocks to specific investors has been approved.